WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
฿5.20
0.00%
(0.00) 1 دن
15 اکتوبر, 4:40:00 PM GMT +7 · THB
search
تمام علامات
| علامت | قیمت | تبدیلی | % تبدیلی |
|---|
insights_autoWUXI06 کے لیے سرفہرست بصیرتیں تخلیق کی جا رہی ہیں...
کھولیں
฿5.25
اعلی
฿5.35
کم
฿5.05
مارکیٹ کی سرمایہ کاری
1.98 کھرب
اوسط والیوم
93.60 ہزار
والیوم
2.89 لاکھ
52 ہفتے میں اعلی
฿6.25
52 ہفتے کا کم
฿3.02
بقایہ شیئرز
4.12 ارب
ملازمین کی تعداد
15 ہزار
کھولیں
฿5.25
اعلی
฿5.35
کم
฿5.05
مارکیٹ کی سرمایہ کاری
1.98 کھرب
اوسط والیوم
93.60 ہزار
والیوم
2.89 لاکھ
52 ہفتے میں اعلی
฿6.25
52 ہفتے کا کم
฿3.02
بقایہ شیئرز
4.12 ارب
ملازمین کی تعداد
15 ہزار
خبریں اور کہانیاں
ویب ذرائع اور خبروں کے پارٹنرز سے
Fierce Biotech
·
1 گھنٹہ پہلے
City goes public with $200M IPO, while Frazier Life Sciences takes biotech-focused SPAC to Nasdaq
Altcoin Buzz
·
25 منٹ پہلے
Garlinghouse Rings Nasdaq Bell as Evernorth Deploys 473M XRP
TradingView
·
1 گھنٹہ پہلے
Key facts: NASDAQ:ASTS delayed 2027; Piper Sandler Neutral; $1B note
Investor's Business Daily
·
4 گھنٹے پہلے
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
پروفائل
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Wuxi Biologics (Cayman) Inc. KKPS DR کے بارے میں